Axcellant is excited to announce our participation at the European Association of Nuclear Medicine (EANM) Congress in Hamburg from October 19-23, 2024. We invite you to visit us and explore how our innovative CRO services in clinical trials and nuclear medicine can support your research and development efforts.
Our team will be available throughout the event to discuss cutting-edge solutions in medical imaging and radiopharmaceutical development. Whether you’re interested in exploring partnership opportunities or learning about our latest projects, we look forward to connecting with you.
See you in Hamburg!
Axcellant participated in SNMMI’s 2025 Annual Meeting in New Orleans, where nearly 8,000 professionals in nuclear medicine and molecular imaging gathered…
Axcellant participated in the PET Symposium 2025, held in Turku, marking 50 years of PET radiochemistry at the Turku PET…
The EU is moving forward with key upgrades to its medical device and diagnostics regulations, specifically under the Medical Device…
Copyright @ 2025 Axcellant